Business Wire Press Release
Gurgaon, Haryana, India: Art of Healing Cancer, one of the leading organizations focused on precision oncology to treat cancer patients, is raising awareness about the high cost of immunotherapy treatment in India by sharing important information on the subject. The organization aims to shed light on the financial burden patients and their families face, advocating for greater accessibility to this life-saving treatment option.
New Delhi, Delhi, India: Art of Healing Cancer, one of the leading precision oncology setups in the country, is excited to present the latest findings on the science of metabolic therapy in treating cancer. This innovative approach alters cancer cells' metabolism to target and inhibit their growth, offering a promising alternative to traditional cancer treatments.
Gurgaon, Haryana, India: Art of Healing Cancer, a globally renowned Precision and integrative oncology institution located in Gurgaon, underscores the possible benefits of incorporating the anti-malarial drug, Artesunate, into cancer treatments. This insight could introduce novel approaches to enhance the effectiveness of traditional cancer therapies.
Sentinel Lymph Node Biopsy (SLNB) is a crucial diagnostic procedure that helps physicians identify and evaluate the first lymph node(s) affected by cancer, known as the sentinel lymph node(s). This assessment is crucial in determining whether cancer has spread beyond its primary site.
Gurgaon, Haryana, India : In the field of cancer research, the tireless efforts of doctors and scientists have led to remarkable breakthroughs in recent years. Innovative work has resulted in the development of new drugs, medicines, and therapies that can either cure or extend the lives of cancer patients.
Art of Healing Cancer, a leading cancer care provider in India, is pleased to share information on the role of liquid biopsy in the management of cancer. This technique is revolutionising cancer care by providing a non-invasive and more accurate way of detecting cancer and monitoring its progression.
Cervical cancer is the fifth most common cancer among women globally according to World Health Organization (WHO). India accounts for one-fifth (1/5th ) of the global burden of the disease. Every year in India, approximately 1.23 lakh women are diagnosed with cervical cancer and around 67,000 die from the disease. It is the second most common cancer affecting women in India. India has a population of approximately 43 crores women aged 15 years and older who are at risk of developing cervical cancer.
In 2020, the combined age-standardised rate for all cancers, excluding non-melanoma skin cancer, was 190 per 100,000, and men had a greater rate of developing cancer (206.9 per 100,000) than women (178.1 per 100,000). Unfortunately, this number has already been surpassed in the year 2022.
Anemia is a condition that affects more than half of cancer patients at diagnosis and during treatment which further impacts their quality of life on an everyday basis. Cancer patients with anemia show reduced response to radiotherapy and chemotherapy due to tumor hypoxia cause by anemia. This condition is further associated with aggressive tumor growth and metastasis. Thus, anemia in a patient who is battling with cancer needs attention and appropriate treatment.
As per the Globocan data 2020, in India, BC accounted for 13.5% (178361) of all cancer cases and 10.6% (90408) of all deaths; hence need measures to either avoid it from developing or reducing recurrence in patients that eventually leads to fatalities. One such measure is Prophylactic Mastectomy, an elective surgery to remove the breasts to reduce the risk of breast cancer in patients carrying a mutation in a specific gene which are hereditary.
Delhi, India: गौरी, मंजू और शाहबाज मध्यम आयु वर्ग के हैं और अपने परिवारों में कमाई का एकलौता ज़रिया हैं। इन तीनों को कैंसर था और ये उपचार का खर्च नहीं उठा सकते हैं।